DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients' clinical management and be a therapeutic target?
作者信息
Lamberti Giuseppe, Peterle Chiara, Gelsomino Francesco
机构信息
Medical Oncology Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy.
Department of Specialized, Experimental and Diagnostic Medicine, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
出版信息
Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S326-S328. doi: 10.21037/tlcr.2018.12.06.
Abstract
摘要
相似文献
1
DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients' clinical management and be a therapeutic target?
Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S326-S328. doi: 10.21037/tlcr.2018.12.06.
2
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration.
Commun Biol. 2018;1:43. doi: 10.1038/s42003-018-0050-6. Epub 2018 May 3.
3
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP.
Cancer Res. 2002 Jul 15;62(14):4061-4.
4
t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism.
Cancer Res. 2008 Jan 15;68(2):395-403. doi: 10.1158/0008-5472.CAN-07-1580.
5
t-Darpp is an elongated monomer that binds calcium and is phosphorylated by cyclin-dependent kinases 1 and 5.
FEBS Open Bio. 2017 Aug 29;7(9):1328-1337. doi: 10.1002/2211-5463.12269. eCollection 2017 Sep.
6
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.
Breast Cancer Res Treat. 2010 Feb;120(1):47-57. doi: 10.1007/s10549-009-0364-7. Epub 2009 Mar 20.
7
Human t-DARPP is induced during striatal development.
Neuroscience. 2016 Oct 1;333:320-30. doi: 10.1016/j.neuroscience.2016.07.022. Epub 2016 Jul 28.
8
Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.
Biochem Pharmacol. 2019 Feb;160:71-79. doi: 10.1016/j.bcp.2018.12.008. Epub 2018 Dec 12.
9
DARPP-32: from neurotransmission to cancer.
Oncotarget. 2016 Apr 5;7(14):17631-40. doi: 10.18632/oncotarget.7268.
10
Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas.
Cancer Res. 2005 Aug 1;65(15):6583-92. doi: 10.1158/0008-5472.CAN-05-1433.
本文引用的文献
1
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
2
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration.
Commun Biol. 2018;1:43. doi: 10.1038/s42003-018-0050-6. Epub 2018 May 3.
3
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
DARPP-32: from neurotransmission to cancer.
Oncotarget. 2016 Apr 5;7(14):17631-40. doi: 10.18632/oncotarget.7268.
5
Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis.
Gut. 2016 Jun;65(6):925-34. doi: 10.1136/gutjnl-2014-308416. Epub 2015 Mar 16.
6
High Expression of DARPP-32 in Colorectal Cancer Is Associated With Liver Metastases and Predicts Survival for Dukes A and B Patients: Results of a Pilot Study.
Int Surg. 2015 Feb;100(2):213-20. doi: 10.9738/INTSURG-D-14-00022.1.
7
Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.
Mol Oncol. 2015 Jan;9(1):270-81. doi: 10.1016/j.molonc.2014.08.008. Epub 2014 Aug 30.
8
Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue.
Mol Cancer. 2014 Aug 15;13:192. doi: 10.1186/1476-4598-13-192.
9
Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma.
Cancer Res. 2012 Sep 1;72(17):4504-14. doi: 10.1158/0008-5472.CAN-12-1119. Epub 2012 Jun 28.
10
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.
Gastroenterology. 2011 Nov;141(5):1738-48.e1-2. doi: 10.1053/j.gastro.2011.06.070. Epub 2011 Jul 7.
Zotero 插件